Geoffrey W. Smith

Mr. Geoffrey Smith has been a member of the board of directors of Orchestra BioMed since May 2018. He previously served on the boards of directors of Caliber Therapeutics, Inc., BackBeat Medical, LLC., and FreeHold Surgical, Inc. He is a co-founder and General Partner of Ascent Biomedical Ventures, LLC (“Ascent”), a New York City-based venture capital firm focused on early-stage life sciences investments, and an investor in Caliber, BackBeat, and FreeHold.

Mr. Smith currently represents Ascent on the Board of Directors for Azevan Pharmaceuticals and BlinkBio and is a Board Observer of Vivasure Medical. He is also the founder and Managing Partner of Digitalis Ventures, a venture capital firm that invests in fundamental new ideas in math and science to address complex health problems. He currently represents Digitalis as a Director of CareDox Inc. and as a Board Observer of Second Genome, Inc. Mr. Smith is a co-founder of Fuse Therapeutics. He is also a Visiting Scholar at Rockefeller University and an adjunct faculty member at the RU Center for Clinical and Translational Science. He is also a member of the Scientific Advisory Board for Brigham & Women’s Hospital in Boston. Previously, he was the founding Director of the Mount Sinai Institute of Technology and a Professor in the Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai. Mr. Smith received a B.A. (with honors) from Williams College and a J.D. from the University of Pennsylvania Law School.